Cadrenal Therapeutics(CVKD) - 2024 Q1 - Quarterly Report
Cadrenal Therapeutics(US:CVKD)2024-05-09 10:23UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OR Commission file number 001-41596 Ponte Vedra, Florida (Address of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 PART I. FINANCIAL INFORMATION | --- | --- | --- | --- | --- | |------------------------------------------------- ...